Clinical outcome | No Laxative use (N=151497) | Laxative use (N=8907) | Oral stimulant containing laxative (N=1603) | Fiber containing laxative (N=5372) | Osmotic containing laxative (N=281) | Stool softener containing laxative (N=2525) | Lubricant containing laxative (N=33) |
---|---|---|---|---|---|---|---|
Falls (> 2) | 50175 (33.9%) | 3484 (40.0%) | 588 (37.7%) | 2040 (38.8%) | 106 (39.3%) | 1067 (43.3%) | 15 (46.9%) |
p-yrs | 959,729 | 53,592 | |||||
Follow-up yrs (SD) / person | 6.4 (2.7) | 6.1 (2.7) | |||||
Hip fracture | 1706 (1.1%) | 142 (1.6%) | 33 (2.1%) | 73 (1.4%) | 4 (1.4%) | 52 (2.1%) | 0 (0.0%) |
p-yrs | 1,171,740 | 67,909 | |||||
Follow-up yrs (SD) / person | 7.8 (1.6) | 7.6 (1.7) | |||||
Total fracture | 21642 (14.3%) | 1476 (16.6%) | 255 (15.9%) | 852 (15.9%) | 48 (17.1%) | 449 (17.8%) | 6 (18.2%) |
p-yrs | 1,053,650 | 61,029 | |||||
Follow-up yrs (SD) / person | 7.2 (2.2) | 7.1 (2.2) |